The influence of alloxan diabetes and starvation for 72 h on the level of rat hepatic fructose 2,6-bisphosphate was investigated. Both diabetes and starvation decreased the level to 10% of the value found in livers of normal, fed rats (10 nmol/g liver). The activity of the enzyme responsible for the synthesis of fructose 2,6-bisphosphate, 6-phosphofructo 2-kinase, was also decreased in livers of diabetic rats. Insulin administration for 24 h to diabetic rats restored the level of fructose 2,6-bisphosphate to normal. Refeeding a high carbohydrate diet for 24 h to starved rats resulted in fructose 2,6-bisphosphate levels that were 2.5-fold higher than that in livers of fed rats. The level of fructose 2,6-bisphosphate in diabetes and starvation, and after refeeding correlates well with the rate of glycolysis and gluconeogenesis in these states and thereby provides further support for its role in regulating hepatic carbohydrate metabolism. DIABETES 30:1062-1064, December 1981.
T he novel sugar diphosphate, fructose 2,6-bisphosphate, is an allosteric activator of 6-phosphofructo 1-kinase 1 " 6 and an inhibitor of fructose 1,6-bisphosphatase. 7 - 8 These reciprocal effects raise the possibility that regulation of the concentration of fructose 2,6-bisphosphate by hormones and/or substrates is an important factor in the control of gluconeogenesis and glycolysis by these enzymes in liver. 6 Glucagon addition to isolated hepatocytes results in a decrease in the level of fructose 2,6 biphosphate.
1 -4 - 6 The hormone acts by a mechanism which involves a cAMP-catalyzed phosphorylation and inactivation of the enzyme responsible for its synthesis, 6-phosphofructo 2-kinase.
6>9
- 10 The present study was undertaken: (1) to investigate whether the level of fructose 2,6-bisphosphate was altered in livers of starved and diabetic rats and in rats starved and then refed a high carbohydrate diet; (2) to study the effect of insulin administration on the level of fructose 2,6-bisphosphate; and (3) to correlate changes in the level of fructose 2,6-bisphosphate with the activity of the enzyme responsible for its synthesis, 6-phosphofructo 2-kinase.
MATERIALS AND METHODS

Materials.
Rabbit muscle aldolase, those phosphate isomerase, and a glycerol phosphate dehydrogenase were obtained from Boehringer Corp (Ridgefield, Connecticut). Trisodium fructose 1,6-bisphosphate, fructose 6-phosphate, and alloxan monohydrate were obtained from Sigma Co. (St. Louis, Missouri). Monocomponent insulin was obtained from Eli Lilly Co. (Indianapolis, Indiana). High carbohydrate test diet was obtained from United States Biochemical Corporation. Animals. Male, Sprague Dawley rats weighing 175-225 g were used. Diabetes was induced by rapid i.v. injection of alloxan monohydrate (60 mg/kg) in 0.9% saline, and the animals were used 3 days later if the blood glucose concentration exceeded 450 mg/dl. Treatment of liver samples. Rats were killed by decapitation, and the livers excised and rapidly freeze-clamped in liquid N 2 as described previously. 11 One gram of frozen liver was homogenized for 30 s in 2 ml of boiling Triethylamine-HCO 3 (TEA-HCO 3 ) buffer, pH 8.4, with an Ultraturrax Homogenizer. The homogenate was heated for 5 min at 80°C, then rapidly cooled, mixed, and centrifuged at 30,000 x a; for 30 min. Charcoal (0.25 ml of 100 mg/ml) was added to 1 ml of the supernatant fraction to remove adenine nucleotides, and after centrifugation, the supernatant fraction was assayed for fructose 2,6-bisphosphate. 6-Phosphofructo 1-kinase activation assay for fructose 2,6-bisphosphate. Fructose 2,6-bisphosphate was determined by comparing the amount of activation of 6-phosphofructo 1-kinase obtained with aliquots of the liver extract with the activation obtained with known concentrations of fructose 2,6-bisphosphate. 6 6-Phosphofructo 1-kinase was assayed as described previously. 12 The activation of pure 6-phosphofructo 1-kinase by fructose 2,6-bisphosphate was roughly linear over the range of 2-10 nM when the enzyme was assayed with 0.2 mM fructose 6-phosphate and 1 mM ATP as substrates. Under these conditions, 10 nM fructose 2,6-bisphosphate activated 6-phosphofructo 1-kinase to about 45% of its maximum activity. Various aliquots of the liver extract were tested for 6-phosphofructo 1-kinase activation, and those volumes that activated the enzyme from 10-45% of maximum activity were used to determine the amount of fructose 2,6-bisphosphate present in the liver. An aliquot of each liver extract was also subjected to acid hydrolysis at pH 3 for 30 min at 22°C to destroy the fructose 2,6-bisphosphate. 5 After neutralization, aliquots were again tested for their ability to activate 6-phosphofructo 1-kinase to determine how much activation was due to effectors other than fructose 2,6-bisphosphate. This value was subtracted from that obtained prior to acid hydrolysis to obtain the activation due solely to fructose 2,6-bisphosphate. To rule out the possible presence of inhibitors of 6-phosphofructo 1-kinase in samples exhibiting an apparently low level of fructose 2,6-bisphosphate, mixing experiments were performed. Increasing aliquots of sample before and after acid hydrolysis were added to samples that partially activated the enzyme. In all cases the amount of fructose 2,6-bisphosphate fell on a linear concentration curve. Fructose 2,6-bisphosphate was prepared as described previously.
5
Assay of 6-phosphofructo 2-kinase and glucokinase. 6-phosphofructo 2-kinase activity was measured by following the production of fructose 2,6-bisphosphate as previously described.
10 Glucokinase was measured as described by Pilkis.
13
Plasma glucose concentrations were determined using the glucose-oxidase method in a Beckman glucose analyzer (Beckman Instruments, Inc., Fullerton, California).
RESULTS
The level of fructose 2,6-bisphosphate in livers from normal, fed rats was 10.4 ± 1.6 nmol/g of liver (Table 1) . Three days after the induction of diabetes with alloxan, blood glucose levels rose to an average of 612 mg/dl and the level of fructose 2,6-bisphosphate decreased to 10% of the normal value. Four hours after the i.p. administration of insulin to a group of diabetic rats, the blood glucose level had decreased to an average of 357 mg/dl and the level of fructose 2,6-bisphosphate had risen to 4.1 nmol/g of liver. Insulin administration for an additional 12 h lowered the blood glucose level to 214 mg/dl but had no further effect on the level of fructose 2,6-bisphosphate. After 24 h of insulin administration, the level of fructose 2,6-bisphosphate was restored to normal. The level of rat hepatic glucokinase showed a similar response to diabetes and subsequent insulin administration (Table 1) . Starvation for 72 h led to a large decrease in the level of fructose 2,6-bisphosphate that was comparable to that seen in diabetes (Table 1) . A similar decrease in the level of fructose 2,6-bisphosphate was observed after only 24 h of starvation. 6 Refeeding a group of 72-h starved rats a high carbohydrate diet for 24 h resulted in levels of fructose, 2,6-bisphosphate that were 2.5-fold greater than the normal fed level. Rat hepatic glucokinase activity also decreased dramatically after 72 h of starvation (Table 1) . Refeeding a high carbohydrate diet for 24 h restored the level of glucokinase but did not increase it to greater than normal levels.
Recently, the enzyme responsible for the synthesis of fructose 2,6-bisphosphate has been identified as 6-phosphofructo 2-kinase.
9>10 Figure 1 shows the effect of diabetes on the activity of 6-phosphofructo 2-kinase measured as a function of the concentration of fructose 6-phosphate. The maximum activity of the enzyme was decreased in livers from diabetic rats and the decrease correlated well with the decrease in the level of fructose 2,6-bisphosphate (Table 1 ). In addition, the affinity of the enzyme for fructose 6-phosphate appeared to be decreased.
DISCUSSION
There are several possible explanations for the large decrease in the hepatic level of fructose 2,6-bisphosphate that occurs in diabetes and starvation. First, both diabetes and starvation are characterized by an elevated level of glucagon and a decreased level of insulin 14 with a resulting increase in hepatic cAMP levels. 11 Glucagon has been shown to act within minutes to lower hepatic fructose 2,6-bisphosphate levels.
1i4i6>15 Since glucagon elevates cyclic AMP levels and 6-phosphofructo 2-kinase has been shown to be inhibited by cyclic AMP-dependent phosphorylation, 6 -16 it is reasonable to postulate that at least part of the decrease in fructose 2,6-bisphosphate levels is due to cyclic AMP- de-TABLE 1 Effect of diabetes, insulin, starvation, and refeeding on hepatic levels of fructose 2,6-bisphosphate and on glucokinase activity. The amount of fructose 2,6-bisphosphate and the activity of glucokinase was determined in extracts of freeze-clamped liver as described under MATERIALS AND METHODS. Diabetic rats were given intraperitoneal injections of 5 U of insulin at 8-h intervals. Animals treated for 4 h, 16 h, and 24 h received one, three, and four injections, respectively. Starved rats were refed a high carbohydrate diet pendent, phosphorylation of the enzyme induced by the elevated levels of glucagon. Second, the results in Figure 1 suggest that the total amount of 6-phosphofructo 2-kinase is decreased in diabetes, since the maximum activity of the enzyme was much less than that found in livers of normal rats. Third, the decreased level of glucokinase may also contribute to the decline in fructose 2,6-bisphosphate levels. The addition of glucose to hepatocytes has been shown to increase the level of this metabolite.
2 ' 15 Decreased levels of glucokinase would limit glucose phosphorylation and \thereby reduce the amount of fructose 6-phosphate available for fructose 2,6-bisphosphate synthesis by 6-phosphofructo 2-kinase. Insulin administration to diabetic rats restores the hepatic level of fructose 2,6-bisphosphate, probably by virtue of its ability to reverse these effects. Work is in progress to determine the relative role of changes in phosphate content and changes in the amount of 6-phosphofructo 2-kinase protein vis a vis regulation of fructose 2,6-bisphosphate concentration.
The decrease in fructose 2,6-bisphosphate levels correlates well with the decreased rates of glycolysis and enhanced rates of gluconeogenesis that are observed in diabetes and starvation. This correlation provides further support for an important role for fructose 2,6-bisphosphate in the regulation of hepatic carbohydrate metabolism in various hormonal and nutritional states. 6 
